A recent study published in The Permanente Journal explored the potential benefits of cannabidiol (CBD) for individuals experiencing anxiety and sleep disturbances.  

CBD, a non-psychoactive compound found in cannabis, has garnered attention for its possible therapeutic effects without inducing a “high.” 

The study conducted a retrospective analysis at a psychiatric clinic, focusing on 72 adults with primary concerns of anxiety (47 participants) or poor sleep (25 participants). Participants received CBD alongside their standard treatment, with most administered a daily dose of 25 mg in capsule form. Those with anxiety typically took CBD in the morning, while individuals with sleep issues consumed it in the evening. 

Findings revealed that within the first month, 79.2% of patients reported decreased anxiety levels, and this reduction was sustained over the study period. Sleep improvements were noted in 66.7% of participants during the initial month, though sleep scores varied in subsequent assessments. Overall, CBD was well tolerated, with only a few patients reporting side effects such as mild fatigue or sedation. 

While these preliminary results are promising, the study still emphasises the need for controlled clinical trials to establish definitive evidence of CBD’s efficacy for anxiety-related disorders.  

As interest in CBD continues to grow, further research will be crucial in determining its role and effectiveness in mental health treatment. 

Read the study here: https://pmc.ncbi.nlm.nih.gov/articles/PMC6326553/